Monthly Archives: June 2017

Bitcoin and Ethereum Just Crashed, Taking Coinbase Down With Them – Fortune

Posted: June 15, 2017 at 8:52 pm

After both hit all-time highs earlier this week, Bitcoin and Ethereum prices plummeted as much as 25% Thursday but many investors were unable to trade for much of the selloff.

Coinbase, a leading cryptocurrency exchange, confirmed that it was completely offline by 9:35 a.m., though the outage appears to have begun several hours earlier, with investors reporting problems on Twitter throughout the night. The company blamed "sustained heavy traffic," likely caused by intense Bitcoin and Ethereum trading, for crashing the Coinbase website and mobile app, which remained completely down for at least four hours.

As has become a familiar frustration to blockchain enthusiasts in recent days, Coinbase went offline at the worst possible time, just as extreme price swings in the cryptocurrencies made investors desperate to buy or sell.

Around 10 a.m. Thursday, the Bitcoin price fell as low as $2079, a more than 30% drop since breaking the $3,000 milestone last weekend (and a 19% decline in the previous 24 hours alone).

At the same time, Ethereum, a rival cryptocurrency whose eye-popping 40-fold gain this year has far outpaced Bitcoin's returns , was down as much as 25% from its price a day earlier. The Ethereum price dipped below $274, just three days after it traded above $400 for the first time.

Coinbase had a similar outage in late May while Bitcoin was trading at record highs, illustrating that new systems for trading blockchain currencies are not yet as reliable as traditional stock market exchanges a lesson a number of investors were learning the hard way, based on their tweets. (While Coinbase initially said it had restored full access to the exchange by mid-afternoon Thursday, it was still trying to repair service for at least some users after 5 p.m., according to a status report on its website.)

Bearish comments by influential investors have triggered several recent selloffs in Bitcoin and Ethereum, such as when Mark Cuban said he thought they were "in a bubble" last week. Morgan Stanley likely contributed to this week's declines by publishing a couple of research notes casting doubt on whether the surge in cryptocurrency prices is justified. "Market likely getting ahead of itself as we have not seen exponential rise in use case yet, but value is rising exponentially," Morgan Stanley analysts wrote in a note Wednesday.

That followed an even more skeptical research report the bank released a day earlier titled "Blockchain: Unchained?" "The rapid appreciation of Bitcoin and others is somewhat surprising in light of some developments that seemingly would have put downward pressure on the currency," another group of Morgan Stanley analysts wrote, citing the SEC's rejection of a Bitcoin ETF , among other factors. "Their values are too volatile and too hard to actually use for payment for most to consider them currencies," they added.

The cryptocurrencies prices bounced back later in the day. As of 6 p.m. Thursday, Bitcoin was down less than 3% and Ethereum was down just under 8% over a 24-hour period.

See original here:
Bitcoin and Ethereum Just Crashed, Taking Coinbase Down With Them - Fortune

Posted in Bitcoin | Comments Off on Bitcoin and Ethereum Just Crashed, Taking Coinbase Down With Them – Fortune

Bitcoin Faces Urgent Scalability Problems – Seeking Alpha

Posted: at 8:52 pm

Bitcoin (Pending:COIN) has more than made its entrance known to businesses and investors alike. With just over 16 million coins in circulation at a current price of about $2750 per coin, BTC currently commands a market cap of over $45 billion, on par with the likes of Ford (NYSE:F), Sony (NYSE:SNE), Barclays (NYSE:BCS), Northrop Grumman (NYSE:NOC), and Activision (NASDAQ:ATVI) to name a few. It's without a doubt that Bitcoin is on the rise and is being incorporated into the investment portfolios of the bold. Bitcoin has its strong selling points, however a large point of contention is looming quite heavily over the cryptocurrency.

Currently, Bitcoin's network can only process a maximum of 7 transactions per second. In reality, the network only handles around 2 to 3 transactions per second, as 7 transactions per second is only a theoretical maximum under optimal conditions. Compare Bitcoin's limitations to VISA or PayPal. Visa handles on average around 2,000 transactions per second, with a daily peak rate of 4,000 transactions per second. VISA has a peak capacity of 56,000 transactions per second, however they never actually use more than a third of this even during peak shopping periods. PayPal handles on average 10 million transactions per day for an average of 115 transactions per second.

Additionally, bitcoin transactions are happening at an increasingly rapid rate. The estimated Daily USD Transaction Value is a good indicator of the number of transactions that occur on a daily basis, and the Daily Transaction Value has shot up to around $2 billion per 24 hours in the 2017 year, compared to the average of under $100 million per day in 2016, an increase of 2000%.

(Image Source: Blockchain.info)

Consequently, as a result of Bitcoin's relatively low maximum transaction speed and its increasing amount of daily transactions, Bitcoin keeps a large backlog of unconfirmed transactions, at one point during the week of May 18th, 2017 reaching a backlog of over 200,000 unconfirmed transactions. This is shown in the size of the mempool, which represents the summed size of the chunks that need to be mined in order to confirm the remaining transactions. The larger the mempool, the more transactions are waiting to be confirmed.

(Image Source: Blockchain.info)

With the increase in unconfirmed transactions, the cost per transaction of bitcoin has shot up. Miners, who are the ones using their computer's processing power to confirm the transactions, need an incentive to pay for electricity and hardware costs. Currently, miners are paid through a combination of Bitcoin's block reward and transaction fees. Currently, each transaction confirmed earns the miner $23. Bitcoin currently rewards 12.5 bitcoins per block, and the average number of transactions per block hangs around 2000. meaning that $17 dollars of the miner's earning for each transaction comes from the mining reward built into the system. This leaves an average cost of around $6 per transaction that users are paying the miners out of pocket for each transaction. $6 is unbelievably high, and eliminates the option of using Bitcoin for microtransactions. Who is going to buy a cup of coffee with Bitcoin when the transaction fee is more than double the cost of the drink!

The way that bitcoin mining works, miners choose which transactions to add to each block that they mine. Transaction fees are actually optional, as in users can select to pay no fee if they so choose. However paying a fee for the transaction gives incentive to the miners to process the transaction as the miner receives the payout from the fee upon completion of the block. With such a large backlog of unconfirmed transactions, users are then incentivized to add larger transaction fees so that their transaction is chosen by miners and not left to fester in the mempool. Essentially, people are willing to pay more to get their transactions confirmed faster. This upward trend in the transaction fee will only continue if the transaction speed bottleneck isn't fixed.

(Image Source: Blockchain.info)

As usage increases, these problems will only exacerbate. If bitcoin wishes to reach widespread adoption, this issue needs to be addressed. Two of the most likely possible solutions are SegWit, which stands for Segregated Witness, and Bitcoin Unlimited.

SegWit is designed to separate signature data from Bitcoin transactions. Regarding scalability, SegWit shrinks the size of each transaction, without changing the transaction size limit of 1 megabyte. This effectively increases the block size limit to around 2 to 3 megabytes per block. However, implementing SegWit requires that 95% of current miners (as in 95% of the total hash power) signals their support for SegWit. If support for SegWit is insufficient, it may result in a contentious fork where a significant part of the network switches to the new SegWit client but some decide to keep using the old one, which results in two cryptocurrencies with different sets of rules competing with each other for users. This would have a strong negative impact on the value of both the currencies. To avoid this, the developers of SegWit have set a specific rule in the software that it will only activate if it receives over 95% support from the network. SegWit has also already been implemented in various other cryptocurrencies and has a proven track record. The problem lies in that SegWit is a temporary solution. The effective increase of each blocksize to 2 to 3 megabytes will be enough for the near future but further down the line, if bitcoin continues its growth, SegWit will not be enough to support the network and congestion in the transaction pool will arise once again.

Bitcoin Unlimited on the other hand is a full node software client for the Bitcoin network. Compared to the Bitcoin Core client (which is what is currently in use) which hard codes the block size limit to 1 megabyte, Bitcoin Unlimited removes the limit and allows users to determine the block size by consensus, allowing the block size to be configured to the preferences of the majority of the miners. Implementing Bitcoin Unlimited presents its own problems, mainly in that it requires Bitcoin to undergo a hard fork, which is irreversible. This means that if any unforeseen bugs or problems arise with Bitcoin Unlimited, the network cannot be reverted back to Bitcoin Core. Unfortunately, unforeseen bugs are a very real possibility on account of the questionable track record of Bitcoin Unlimited's small development team. Currently, around 12% of the entire Bitcoin network is running Bitcoin Unlimited, and if you have been paying attention to cryptocurrency news, Bitcoin Unlimited has been targeted with DoS attacks on more than one occasion, originating from a bug in the Bitcoin Unlimited software that left an opening for the attack.

Either way, neither solution is truly permanent. As Bitcoin continues to grow, it needs to simultaneously and continuously address its need for greater scalability. Without the necessary changes, Bitcoin will eventually fall off the main stage.

I will be covering the upcoming events of August 1st in my next article.

Disclosure: I am/we are long BTC.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Visit link:
Bitcoin Faces Urgent Scalability Problems - Seeking Alpha

Posted in Bitcoin | Comments Off on Bitcoin Faces Urgent Scalability Problems – Seeking Alpha

Where no loaf has gone before – The Hindu

Posted: at 8:51 pm


The Hindu
Where no loaf has gone before
The Hindu
However, German startup Bake In Space is now determined to take the sandwich back into orbit. And they've given themselves an ambitious deadline: Alexander Gerst's mission to the International Space Station in May 2018. He's a German astronautand ...
Bake in Space aims to develop crumb-free bread for astronautsHerald Sun

all 3 news articles »

Visit link:
Where no loaf has gone before - The Hindu

Posted in Space Station | Comments Off on Where no loaf has gone before – The Hindu

Genetic engineering lobbyist’s Trumpian methods – Caribbean Life

Posted: at 8:50 pm

Subscribe

Get our stories in your inbox, free.

Like Caribbean Life on Facebook.

Jomo Kwame Sundaram, a former economics professor and United Nations Assistant Secretary-General for Economic Development, received the Wassily Leontief Prize for Advancing the Frontiers of Economic Thought in 2007.

KUALA LUMPUR, June 13 2017 (IPS) - To her credit, Dr. Mahaletchumy has pioneered and promoted science journalism in Malaysia. This is indeed commendable in the face of the recent resurgence of obscurantism of various types, both traditional and modern.

But she has done herself, journalism and science a great disservice by using her position of influence to lobby for her faith in genetic engineering, promoting another obscurantism in the guise of science. In her blatantly polemical GE advocacy, she uses caricature and rhetoric to misrepresent and defame those she disagrees with.

She accuses us of spreading flawed arguments and inaccurate information, demonising private industry, and making a number of sweeping statements with inaccuracies about lower yield gains with genetically engineered crops, higher usage of herbicides, decline in crop and (sic) biodiversity, rising pest resistance, carcinogenicity of glyphosate, and increase in corporate power.

To be sure, our article was never intended for a scientific journal, but rather for IPS readers to appreciate the implications of recent research. It nevertheless provided links to relevant research for those interested, which she chose to ignore while accusing us of lying (false news) in Trumpian fashion.

Most importantly, she does not directly refute any of our arguments or the evidence that the increased output from non-GE crops has exceeded the productivity growth of GE crops due to, among others, the rise of pesticide resistance our main argument. Nor does she bother to refute the mounting evidence of greater farmer reliance on commercial agrochemicals, especially herbicides.

GE advocates cannot have it both ways. One cannot insist that only GE can increase output and productivity as well as improve farmers net incomes and the environment without offering or citing systematic evidence, and simply reject inconvenient evidence to the contrary.

Dr. Mahaletchumy fails to actually quote anything we actually wrote or to show how the sources we use are wrong. Her effort to discredit us resorts to innuendo and insinuation. While accusing us of selective citation, she has little hesitation to do what she condemns, citing only one person, Graham Brookes, not once, but twice, to make her case.

Instead of creating false news, as she claims we did, inter alia, we relied on and provided links to the US National Academy of Sciences report on Genetically Engineered Crops. The report provides an authoritative review of the now very considerable and diverse research on related issues. While the encyclopaedic volume admittedly includes a bland summary, the report itself offers a richly textured survey of evidence from many peer-reviewed studies.

She also refuses to recognize that most people go hungry in the world because they cannot afford access to the food they need and not because there is not enough food grown in the world.

Meanwhile, government and philanthropic funding of public research and development has declined while private corporate interests have been promoting GE, not exactly for charitable reasons.

We draw conclusions which other science journalists have also drawn, but instead of critically addressing our arguments, she lumps us together with GE critics, and invokes the same arguments and sources of the heavily corporate funded GE lobby.

Let me be very clear. We are keen supporters of technological progress, including biotechnology. And as we made clear, genetic modification is as old as nature itself. Unlike GE opponents, we remain open-minded about it.

Dr. Mahaletchumy is correct that there continues to be some debate over whether glyphosates are carcinogenic. This is partly why we insist on adherence to long established scientific ethics, including the precautionary principle.

But one cannot go authority shopping by dismissing the World Health Organization when it is inconvenient, and citing any body saying otherwise, especially when its authority is not relevant as she does.

We have previously shown how misleading research findings funded by the US Sugar Foundation had damaging consequences for world health for half a century.

We are also concerned about the unintended consequences of scientific progress. For example, the excessive use of cheap antibiotics for both humans and animals has generated antibiotic-resistant bacteria for every class of antibiotics, with annual mortality rates due to antibiotic resistant diseases expected to rise exponentially to ten million by mid-century.

One wonders why a journalist resorts to fraudulent misrepresentation in the cause of any advocacy, or in this case, to deceptively insist that her faith that GE is the only way forward is irrefutable science.

Updated 4:45 pm, June 15, 2017

2017 Community News Group

Subscribe

Get our stories in your inbox, free.

Like Caribbean Life on Facebook.

Continued here:
Genetic engineering lobbyist's Trumpian methods - Caribbean Life

Posted in Genetic Engineering | Comments Off on Genetic engineering lobbyist’s Trumpian methods – Caribbean Life

Gut bacteria might one day help slow down aging process – Baylor College of Medicine News (press release)

Posted: at 8:50 pm

Slowing down the aging process might be possible one day with supplements derived from gut bacteria. Scientists at Baylor College of Medicine and the University of Texas Health Science Center at Houston have identified bacterial genes and compounds that extend the life of and also slow down the progression of tumors and the accumulation of amyloid-beta, a compound associated with Alzheimers disease, in the laboratory worm C. elegans. The study appears in the journal Cell.

The scientific community is increasingly aware that our bodys interactions with the millions of microbes in our bodies, the microbiome, can influence many of our functions, such as cognitive and metabolic activities and aging, said corresponding author Dr. Meng Wang, associate professor of molecular and human genetics at Baylor and the Huffington Center On Aging. In this work we investigated whether the genetic composition of the microbiome might also be important for longevity.

This question is difficult to explore in mammals due to technical challenges, so the researchers turned to the laboratory worm C. elegans, a transparent, simple organism that is as long as a pinhead and shares essential characteristics with human biology. During its 2 to 3 week long lifespan, the worm feeds on bacteria, develops into an adult, reproduces, and progressively ages, loses strength and health and dies. Many research laboratories around the world, including the Wang lab, work with C. elegans to learn about basic biological processes.

We think that C. elegans is a wonderful system in which to study the connection between bacterial genes and aging because we can very fine tune the genetics of microbes and test many genes in the worm in a relatively short time, Wang said.

Testing thousands of genes, one at a time.

To study the effect of individual bacterial genes on the lifespan of C. elegans, Wang joined efforts with Dr. Christophe Herman, associate professor of molecular and human genetics and molecular virology and microbiology at Baylor, and other colleagues who are experts in bacterial genetics. They employed a complete gene-deletion library of bacterium E. coli; a collection of E. coli, each lacking one of close to 4,000 genes.

We fed C. elegans each individual mutant bacteria and then looked at the worms life span, Wang said. Of the nearly 4,000 bacterial genes we tested, 29, when deleted, increased the worms lifespan. Twelve of these bacterial mutants also protected the worms from tumor growth and accumulation of amyloid-beta, a characteristic of Alzheimers disease in humans.

Further experiments showed that some of the bacterial mutants increased longevity by acting on some of the worms known processes linked to aging. Other mutants encouraged longevity by over-producing the polysaccharide colanic acid. When the scientists provided purified colanic acid to C. elegans, the worms also lived longer. Colanic acid also showed similar effects in the laboratory fruit fly and in mammalian cells cultured in the lab.

The researchers propose that, based on these results, it might be possible in the future to design preparations of bacteria or their compounds that could help slow down the aging process.

Colanic acid mediates crosstalk between bacteria and mitochondria

Interestingly, the scientists found that colanic acid regulates the fusion-fission dynamics of mitochondria, the structures that provide the energy for the cells functions.

These findings are also interesting and have implications from the biological point of view in the way we understand host-microbe communication, Wang said. Mitochondria seem to have evolved from bacteria that millions of years ago entered primitive cells. Our finding suggests that products from bacteria today can still chime in the communication between mitochondria in our cells. We think that this type of communication is very important and here we have provided the first evidence of this. Fully understanding microbe-mitochondria communication can help us understand at a deeper level the interactions between microbes and their hosts.

Other contributors to this work include Bing Han, Priya Sivaramakrishnan, Chih-Chun J. Lin, Isaiah A.A. Neve, Jingquan He, Li Wei Rachel Tay, Jessica N. Sowa, Antons Sizovs, Guangwei Du and Jin Wang.

Financial support for this project was provided by the National Institutes of Health grants R01AG045183, R01AT009050, DP1DK113644, R01HL119478, R01GM088653, R01GM115622, R01CA207701 and Howard Hughes Medical Institute Faculty Scholar Award.

See the original post:
Gut bacteria might one day help slow down aging process - Baylor College of Medicine News (press release)

Posted in Human Genetics | Comments Off on Gut bacteria might one day help slow down aging process – Baylor College of Medicine News (press release)

Newly revealed cellular pathway may lead to cancer therapies – Baylor College of Medicine News (press release)

Posted: at 8:50 pm

Scientists have discovered a new cellular pathway that can promote and support the growth of cancer cells. In a mouse model of melanoma, blocking this pathway resulted in reduction of tumor growth. The study, which appears in Science, offers a novel opportunity to develop drugs that could potentially inhibit this pathway in human cancer cells and help control their growth.

We had been studying components of this pathway for several years, said senior author Dr. Andrea Ballabio, professor of molecular and human genetics at Baylor College of Medicine and Texas Childrens Hospital in Houston, Texas, and director of the Telethon Institute of Genetics and Medicine in Naples, Italy. We know that the pathway is important for normal cells to carry their activities as it is involved in regulating metabolism, that is, how cells process nutrients to obtain energy and how cells use energy to grow. In this study we wanted to learn more about how the pathway regulates its activity.

Pathways involved in cellular metabolism typically regulate themselves, meaning that some components of the pathway control each others activities. We suspected that the pathway was autoregulated, and we confirmed it in this study. Our experimental approaches showed that there is a feedback loop within the path that allows it to control itself.

An important pathway for normal cellular activities

Ballabio and his colleagues studied the role of the pathway in two normal cellular activities; how cells respond to physical exercise and how they respond to nutrient availability. In terms of physical exercise, the researchers determined that the self-regulating mechanism they discovered is essential for the body builder effect.

Some athletes take the aminoacid leucine or a mixture of aminoacids immediately after exercising, which promotes protein synthesis that leads to muscle growth. This is the body builder effect, Ballabio said. When we genetically engineered mice to lack the pathway, we lost the body builder effect.

The researchers had a group of normal mice and another of mice lacking the pathway. Both groups were set to exercise and fed leucine immediately after. While normal mice showed enhanced protein synthesis, the mice without the pathway did not.

In healthy organisms, this pathway also allows cells to adapt more efficiently to nutrient availability, Ballabio said. For example, when transitioning from a period of starvation to one in which food is available, cells need to switch from catabolism to anabolism. Starvation promotes catabolism the breakdown of nutrients to obtain energy to function and eating promotes anabolism the buildup of molecules, such as proteins. The feedback we discovered mediates the switch from catabolism to anabolism, allowing organisms to adapt to food availability.

An important pathway for cancer growth

The scientists also studied the role this pathway might play in cancer cells. They discovered that overactivation of this pathway, which is observed in some types of cancer such as renal cell carcinoma, melanoma and pancreatic cancer, is important to promote and support the growth of cancer cells in culture and animal models.

Most importantly, we demonstrated in our study that blocking the pathway resulted in reduction of tumor growth in an experimental model of human melanoma transplanted into mice, Ballabio said. I am most excited about the future potential therapeutic applications of this discovery against cancer. Developing pharmacological treatments that interfere with this pathway might one day help stop tumor growth.

Rare disease discoveries can improve our understanding of common diseases

Our lab focuses on rare genetic diseases, such as lysosomal storage genetic disorders, in which we originally studied this pathway, Ballabio said. Then, we discovered that the pathway is also important in cancer. Our and other researchers work on rare genetic diseases sometimes produces findings that can potentially be applicable to more common diseases, such as cancer.

For a complete list of the authors of this work and their affiliations, please refer to the published article.

This study was supported by grants from the Italian Telethon Foundation (TGM11CB6); European Research Council Advanced Investigator grant no. 250154 (CLEAR) and no. 341131 (InMec); U.S. National Institutes of Health (R01-NS078072); and the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.) IG 2015 Id 17639 and IG 2015 Id 17717.

Read more:
Newly revealed cellular pathway may lead to cancer therapies - Baylor College of Medicine News (press release)

Posted in Human Genetics | Comments Off on Newly revealed cellular pathway may lead to cancer therapies – Baylor College of Medicine News (press release)

Gut Bacteria Could Impact Aging – R & D Magazine

Posted: at 8:50 pm

A bacteria in the gut may could hold the key to slowing down the aging process.

Scientists from Baylor College of Medicine and the University of Texas Health Science Center at Houston have found bacterial genes and compounds that extend the life of and slow down the progression of tumors and the accumulation of amyloid-beta, which is associated with Alzheimers disease.

The scientific community is increasingly aware that our body's interactions with the millions of microbes in our bodies, the microbiome, can influence many of our functions, such as cognitive and metabolic activities and aging, corresponding author Meng Wang, Ph.D., associate professor of molecular and human genetics at Baylor and the Huffington Center On Aging, said in a statement.

In this work we investigated whether the genetic composition of the microbiome might also be important for longevity, she added.

The researchers have identified the genes and compounds in C. elegans, a laboratory worm that is a transparent, simple organism that share essential characteristics with human biology.

The worm only lives two-to-three weeks and feeds on bacteria. However, it does progressively age to develop into an adult, while also reproducing.

We think that C. elegans is a wonderful system in which to study the connection between bacterial genes and aging because we can very fine tune the genetics of microbes and test many genes in the worm in a relatively short time, Wang said. We fed C. elegans each individual mutant bacteria and then looked at the worms' life span.

Of the nearly 4,000 bacterial genes we tested, 29, when deleted, increased the worms' lifespan. Twelve of these bacterial mutants also protected the worms from tumor growth and accumulation of amyloid-beta, a characteristic of Alzheimer's disease in humans.

The researchers then discovered that some of the bacterial mutants increased longevity by acting on some of the worms known processes linked to aging. After providing purified colonic acid to the worms, the researchers found that they lived longer.

Based on these results the researchers believe it is possible to design preparations of bacteria or their compounds that could help slow down the aging process.

See the original post here:
Gut Bacteria Could Impact Aging - R & D Magazine

Posted in Human Genetics | Comments Off on Gut Bacteria Could Impact Aging – R & D Magazine

A new video shows you exactly what it looks like when DNA replicates – Mashable

Posted: at 8:49 pm


Mashable
A new video shows you exactly what it looks like when DNA replicates
Mashable
Scientists at the University of California, Davis, captured DNA replication on video for the first time. The 11-second clip which kind of looks like something pulled from a 1970s video game shows glowing strands of DNA stretching from left to ...
Scientists Watch DNA Copy And Paste Itself For The First TimeInternational Business Times

all 2 news articles »

Link:
A new video shows you exactly what it looks like when DNA replicates - Mashable

Posted in DNA | Comments Off on A new video shows you exactly what it looks like when DNA replicates – Mashable

To Keep DNA Lounge Open, Owner Closes Two Other Businesses … – Eater SF

Posted: at 8:49 pm

The SoMa all-ages venue Codeword and its adjoining pizza restaurant DNA Pizza will close at the end of July according to owner Jamie Zawinski. The nightclub proprietor, who also owns and operates the larger DNA Lounge, revealed the news on his blog yesterday, explaining that closing Codeword and DNA Pizzeria could help the already embattled DNA Lounge survive.

Zawinksi signed the lease on his second, smaller venue Codeword at 917 Folsom (5th and Folsom) in 2015 amid better business at his flagship club, DNA Lounge. Since then, things have taken a bad turn for the businesses generally, as Zawinski first confided in a December blog post.

Formerly a software engineer, Zawinski opened DNA Lounge with his winnings in the Startup Lottery, but after spending an estimated $5 million on it without turning a profit, hes run out of money. Now, unless he sees an uptick in attendance at DNA Lounge and support in the form of donations from patrons, Zawinski says hell have to close his club. But first, the ax is coming down for its spinoff, Codeword.

Rather than blaming high rent as a cause of Codewords closure, Zawinski actually thanks his landlord, who even lowered the rent and allowed Zawinski to break his lease when he couldnt find anyone to buy the business and take over the lease. Most of all, Zawinski thanked all of the artists and promoters who made a go of it at the club.

But will closing Codeword and DNA Pizzeria save DNA Lounge? Zawinski doesnt sound optimistic. Overall, we're still pretty fucked, he writes. Getting rid of Codeword staunches the flow, but we're still bleeding out, every damned day.

To help, you can donate to the clubs Patreon account, or go dance at Bootie, the weekly dance/sweat party held at DNA Lounge.

Continued here:
To Keep DNA Lounge Open, Owner Closes Two Other Businesses ... - Eater SF

Posted in DNA | Comments Off on To Keep DNA Lounge Open, Owner Closes Two Other Businesses … – Eater SF

New concerns raised over value of genome-wide disease studies – Nature.com

Posted: at 8:49 pm

Sandor Csudai/Getty Images

Genome-wide association studies search through huge groups of people to find DNA variants linked to diseases or traits.

Compare the genomes of enough people with and without a disease, and genetic variants linked to the malady should pop out. So runs the philosophy behind genome-wide association studies (GWAS), which researchers have used for over a decade to find genetic ties to diseases such as schizophrenia and rheumatoid arthritis. But a provocative analysis now calls the future of that strategy into question and raises doubts about whether funders should pour more money into these experiments.

GWAS are fast expanding to encompass hundreds of thousands even millions of patients (see 'The genome-wide tide'). But biologists are likely to find that larger studies turn up more and more genetic variants or 'hits' that have minuscule influences on disease, says Jonathan Pritchard, a geneticist at Stanford University in California. It seems likely, he argues, that common illnesses could be linked by GWAS to hundreds of thousands of DNA variants: potentially, to every single DNA region that happens to be active in a tissue involved in a disease.

In a paper published in Cell on 15 June1, Pritchard and two other geneticists suggest that many GWAS hits have no specific biological relevance to disease and wouldnt serve as good drug targets. Rather, these 'peripheral' variants probably act through complex biochemical regulatory networks to influence the activity of a few core genes that are more directly connected to an illness.

The implicit assumption of GWAS has been that when you find hits, they should be directly involved in the disease youre studying, he says. When you start to think that all of the expressed genes in a tissue can matter, it becomes untenable that theres a simple biological story for each one.

Many geneticists say they think Pritchard's view could be correct and that he articulates widely-held concerns about the difficulty of interpreting GWAS findings because of gaps in understanding about biochemical networks. I think its pretty plausible, says Joe Pickrell, a human geneticist at the New York Genome Center in New York City. We might not actually be learning anything hugely interesting until we understand how these networks are connected.

Rather than more and bigger GWAS, researchers and funders should devote their efforts to mapping regulatory networks in cells, Pritchard argues. Biologists that aim to link genes with diseases, he says, should focus on identifying the mutations that directly cause disorders; some of these variants are so rare that they aren't picked up in GWAS.

GWAS experiments have identified some genes that contribute to the risk of developing conditions such as obesity, but they have also thrown up plenty of vexing problems. Most of the hits found in GWAS dont seem to encode genes that make proteins, so it is hard to interpret their connection to a disease or trait. And even for traits that are known to be highly heritable suggesting that they have a large genetic influence the cumulative influence of all the DNA variants spotted by GWAS doesnt fully explain the variation seen between people. A 2014 study of 250,000 people, for example, identified nearly 700 DNA variants linked to height: but together, they explain only about 16% of differences in height across a population2.

In the Cell paper, Pritchards team re-analysed the data from the 2014 study. The researchers estimate that as many as 100,000 single-letter DNA variants can influence a persons height, but each one has a minuscule impact; on average just about one-tenth of a millimetre. These variants tend to lie in regions that do not themselves encode genes but which influence the activity of regions that do.

The researchers also re-analysed data from GWAS of schizophrenia, rheumatoid arthritis and Crohns disease. They found GWAS hits in DNA regions that are expressed in the particular cells relevant to the disease: neurons for schizophrenia, and immune cells for the two autoimmune diseases. But regions of DNA active in many types of body tissue were just as likely to be hits as those that were active only in neurons or immune cells, the team found. That lends credence to the idea that large GWAS are simply picking up most of the DNA variants that have an influence on gene regulation, and that happen to be active in broad functions of disease-relevant cells, rather than in particular activities linked to illness.

This doesnt mean that researchers should stop carrying out GWAS studies, some geneticists say. Although GWAS hits might be peripheral to a disease, identifying more of them enables scientists to knit together the biological networks implicated in a disease and understand how they interact, says Mark McCarthy, a human geneticist at the University of Oxford, UK, who is working on a GWAS of type 2 diabetes involving around 1 million participants. Those of us who do ever bigger GWAS, we dont just simply crank the handle, he says. Were motivated by lots of biological insights coming out of GWAS.

And Joel Hirschhorn, a human geneticist at Children's Hospital Boston, says that not all hits uncovered by very large GWAS are peripheral. The 2014 height study, which Hirschhorn co-led, uncovered an association to an important growth factor that wasn't picked up in a smaller GWAS study of height, he points out.

But Aravinda Chakravarti, a human geneticist at Johns Hopkins University in Baltimore, Maryland, hopes that the paper will challenge what he terms a cowboy attitude in genomics research that emphasizes collecting ever more genetic associations over understanding the deeper biology behind them. This is a nice paper simply because its going to kick people in the shin, which, as scientists, we need from time to time.

Read more here:
New concerns raised over value of genome-wide disease studies - Nature.com

Posted in Genome | Comments Off on New concerns raised over value of genome-wide disease studies – Nature.com